.
MergerLinks Header Logo

Announced

Pfizer to acquire Arixa Pharmaceuticals.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private

Domestic

Pharmaceuticals

Pending

Majority

Single Bidder

pharmaceuticals

Acquisition

Friendly

United States

Synopsis

Edit

Pfizer, a pharmaceutical corporation, through its Hospital business, agreed to acquire Arixa Pharmaceuticals, a pharmaceutical company. Financial terms were not disclosed. “Through this acquisition, Pfizer will advance the development program for Arixa’s leading asset, ARX-1796. We are excited by the potential benefits ARX-1796 may provide to patients and the healthcare system overall, potentially allowing patients to leave the hospital earlier or avoid the need for hospital admission altogether,” Annaliesa Anderson, Pfizer Vice President and Chief Scientific Officer Bacterial Vaccines and Hospital.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US